Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...

Investing.com -- Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) stock surged 10% after the company announced positive topline results from its Phase 2 trial evaluating bivamelagon, an investigational oral m ...

Question: I have a seven-year-old daughter who is getting a little chubby. I give her fresh, healthy food in appropriate ...

To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks -- -- Post-hoc analysis showed BMI reduction ...

Merck is acquiring UK-based Verona Pharma for about $10 billion, as part of the U.S. drugmaker's strategy to diversify beyond ...

Top-Line Data Expected in the Fourth Quarter of 2025 CAMBRIDGE, Mass., July 9, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology ...

The European Association for the Study of Obesity (EASO) framework may offer a more sensitive measure of obesity tha ...

Dror Dicker of Hasharon Hospital has led to a major shift in how obesity is defined in the United States, with around 50 ...

Hims & Hers Health, Inc. (NYSE: HIMS) the leading digital health and wellness platform, today announced its plans to bring ...

Remember former Rep. Jamaal Bowman (D-N.Y.) who got censured for pulling the fire alarm in the Capitol Building as lawmakers ...

Novo Nordisk is a global diabetes and weight loss leader with strong long-term growth prospects. Read why NVO stock is a ...